Roprestim/Romigrastim and Qilu Pharmaceutical: Hope and Prospects of Domestic Generic Drugs

Romiplostim/Romiplostim, trade name: Vergel, is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia (ITP). In recent years, with the rapid development of the domestic pharmaceutical industry, domestic pharmaceutical companies such as Qilu Pharmaceutical have begun to develop biosimilar drugs. Many patients are therefore concerned: Have domestic generic drugs of Ropremilastin been released? This article will provide you with a detailed analysis of this topic from the aspects of Qilu Pharmaceutical’s research and development progress, the significance of generic drugs and patients’ expectations.

At present, the original drug of Roprostim has been launched in China and included in the medical insurance catalog, but its price is relatively high. Although Medicare reimbursement can alleviate some of the financial burden, cost remains a significant issue for patients requiring long-term treatment. Therefore, the research and development of domestic generic drugs is highly anticipated. As a leading pharmaceutical company in China, Qilu Pharmaceutical has been committed to the research and development of biosimilar drugs, and there is already news of the launch of generic drugs of Ropremilast.

The launch of domestic generic drugs is of great significance to patients. First, the price of generic drugs is usually much lower than that of original drugs, which can significantly reduce the financial burden on patients. Secondly, the launch of generic drugs can increase market competition and drive down the price of original drugs, thereby benefiting more patients. In addition, the R&D and production of domestic generic drugs will also help improve the independent innovation capabilities of the domestic pharmaceutical industry and promote the development of the entire industry.

Although domestic generic versions of Ropremilast are already on the market, patients can also reduce financial pressure through other means. For example, participate in pharmaceutical industry assistance programs or charitable drug gift programs, which often provide partial cost reduction or free drug support to patients in financial need. In addition, patients can also pay attention to the dynamics of national medical insurance policies to learn whether there are new reimbursement policies or assistance plans.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim